Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Not applicableStudy completedNCT05889637
What this trial is testing

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 132
Large-scale testing (Phase 3)Study completedNCT02042664
What this trial is testing

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Who this might be right for
ObesityDiabetes
Assistance Publique Hopitaux De Marseille 44
Not applicableLooking for participantsNCT07229170
What this trial is testing

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Who this might be right for
Obesity & OverweightTaste AlterationsWeight Loss+1 more
San Raffaele Telematic University 150
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Not applicableLooking for participantsNCT07006142
What this trial is testing

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Who this might be right for
Upper EndoscopyGLP1-R-related Disease
Mayo Clinic 150
Early research (Phase 1)Not Yet RecruitingNCT06562088
What this trial is testing

A Drug-Drug Interaction (DDI) Study of HDM1002 With Rifampicin and Itraconazole in Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 40
Not applicableStudy completedNCT07360262
What this trial is testing

Gastric Emptying Recovery After GLP-1 RA Cessation

Who this might be right for
Gastric EmptyingGastroparesisPreoperative Care
Wonkwang University Hospital 186
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Post-approval studies (Phase 4)UnknownNCT02501850
What this trial is testing

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

Who this might be right for
Diabetes Mellitus Type 2
Hospital Universitari Vall d'Hebron Research Institute 40
Not applicableStudy completedNCT07269821
What this trial is testing

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

Who this might be right for
GLP-1Weight Loss TrajectoryEmotional Disorder+1 more
University of Alicante 70
Testing effectiveness (Phase 2)Study completedNCT06481085
What this trial is testing

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 324
Post-approval studies (Phase 4)Study completedNCT05786521
What this trial is testing

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

Who this might be right for
AgingDiabetes Mellitus, Type 2PreDiabetes+1 more
The University of Texas Health Science Center at San Antonio 20
Testing effectiveness (Phase 2)Study completedNCT06282458
What this trial is testing

Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt

Who this might be right for
Muscle LossObesity
Veru Inc. 168
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Not applicableLooking for participantsNCT07244458
What this trial is testing

Dietary Peanuts and Nutrition-Related Outcomes

Who this might be right for
Dietary ChangeObesity & OverweightFood Acceptance
Ian J. Neeland, MD 64
Very early researchNot Yet RecruitingNCT07627191
What this trial is testing

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Who this might be right for
Pancreatic CancerColorectal CancerHepatocellular Carcinoma
University of Arizona 30
Very early researchEnrolling By InvitationNCT07092605
What this trial is testing

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Who this might be right for
LongevityQuality of LifeMood+5 more
AgelessRx 150
Testing effectiveness (Phase 2)Study completedNCT03712098
What this trial is testing

Daily Liraglutide for Nicotine Dependence

Who this might be right for
Smoking CessationWeight, Body
Rebecca Ashare 40
Load More Results